| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -80.7% |
| R&D Expense | $169.8M | +8.9% |
| SG&A Expense | $109.3M | +10.4% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$311.9M | -4.7% |
| Income Tax | -$25K | +94.4% |
| Net Income | -$311.9M | -4.9% |
| EPS (Basic) | -$8.54 | -4.3% |
| EPS (Diluted) | -$8.54 | -4.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.3M | -92.8% |
| Short-term Investments | $345.2M | — |
| Current Assets | $397.8M | -33.3% |
| Total Assets | $514.5M | -30.0% |
| Current Liabilities | $59.0M | +9.2% |
| Stockholders' Equity | -$65.7M | -135.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$204.3M | +13.3% |
| Capital Expenditures | $3.3M | +146.0% |
| Investing Cash Flow | -$345.2M | — |
| Financing Cash Flow | $1.5M | -83.7% |
| Free Cash Flow | -$207.5M | +12.4% |